PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705750
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1705750
Global Breast Lesion Localization Methods Market is estimated to be valued at USD 461.5 Mn in 2025 and is expected to reach USD 770.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 461.5 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 7.60% | 2032 Value Projection: | USD 770.7 Mn |
Breast cancer is one of the most common cancers diagnosed in women globally. Various methods have been developed for effective localization of breast lesions to aid in biopsy and surgical removal. Breast lesion localization methods help surgeons to accurately identify and remove the lesions, thus playing a crucial role in breast cancer management. Traditionally, wire guided localization was used which involved placement of a hook wire into the breast lesion under ultrasound or mammogram guidance before surgical procedure. However, wire guided localization had few limitations including displacement of the wire during surgery. In recent years, advanced localization methods like radioisotope guided localization and magnetic tracer guided localization have been introduced in the market to overcome the challenges with wire guided localization. These novel techniques provide improved accuracy and convenience for surgeons performing breast procedures. Overall, effective localization of breast lesions remains an important aspect of breast healthcare with ongoing innovations which are expected to further enhance outcomes.
Global breast lesion localization methods market is driven by rising prevalence of breast cancer worldwide. According to World Health Organization (WHO), breast cancer is the most common cancer among women with over 2 million new cases reported in 2018. Growing awareness about early detection and screening of breast cancer is also promoting the adoption of advanced localization solutions. However, high costs associated with radioisotope and magnetic tracer based localization methods could hamper market growth. On the positive side, ongoing research and development (R&D) in this field is expected to bring down the costs with time. Favorable reimbursement policies for breast cancer diagnostic procedures in developed nations present lucrative opportunities. Technological advancements are further expanding applications of localization methods beyond biopsy to include tumor margin assessment during surgeries.